Charles Bennett to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications Charles Bennett has written about Antiretroviral Therapy, Highly Active.
Connection Strength
1.710
-
Single- versus multiple-tablet HIV regimens: adherence and hospitalization risks. Am J Manag Care. 2016 04; 22(4):242-8.
Score: 0.490
-
Adverse drug interactions: moving from perception to action. Pharmacoeconomics. 2010; 28(1):19-22.
Score: 0.318
-
Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care. 2005 Oct; 17(7):863-73.
Score: 0.237
-
US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era. Chest. 2004 Feb; 125(2):548-56.
Score: 0.211
-
HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J Gen Intern Med. 2001 Sep; 16(9):583-9.
Score: 0.178
-
Racial variations in care and outcomes for inpatient HIV-related pneumocystis pneumonia. J Health Care Poor Underserved. 2010 Feb; 21(1):318-33.
Score: 0.080
-
Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns. 2007 Feb; 65(2):253-60.
Score: 0.064
-
Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS. 2006 May; 20(5):359-68.
Score: 0.062
-
HIV-related pneumonia care in older patients hospitalized in the early HAART era. AIDS Patient Care STDS. 2004 Feb; 18(2):99-107.
Score: 0.053
-
Hepatotoxicity associated with long- versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And Reports (RADAR) project. Drug Saf. 2009; 32(2):147-58.
Score: 0.019